Indications
Treatment of symptomatic multiple myeloma
Composition
- Active substance
- dexamethasone
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Neofordex
- Active substance
- dexamethasone
- ATC code
- H02AB02
- Therapeutic area
- Multiple Myeloma
- Marketing authorisation holder
- Laboratoires CTRS - Boulogne Billancourt
- Status
- Application withdrawn
- EMA product number
- EMEA/H/C/002418